Samsung Biologics signed a 92.7 billion won CMO contract with MSD

Reporter Kim Jisun / approved : 2024-03-13 03:58:11
  • -
  • +
  • 인쇄

Samsung Biologics. (Photo = Samsung Biologics)

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Samsung BioLogics said in a public announcement on the 12th that it has signed a KRW 92.7 billion consignment production contract with global pharmaceutical company MSD Switzerland. This is equivalent to 3.09% of sales as of 2022.

The contract period can be changed according to the agreement between the two companies until December 31, 2032.

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

Paris Croissant Issues Voluntary Recall of “Dried Persimmon Pound Cake” Due to Allergen Labeling Omissio2025.09.18
Hyundai Motor Group Restores Vehicle Control Apps After 10-Hour Outage2025.09.18
HMM Completes Share Buyback Worth KRW 2.14 Trillion2025.09.18
Gyeonggi Police Arrest Two Chinese Nationals Over KT Mobile Payment Hacking Scheme2025.09.18
Financial Services Commission Imposes ₩3.66 Billion in Fines on STX and STX Marine Service for Accounting Violations Related to Overseas Litigation2025.09.18
뉴스댓글 >